System and Method for Testing for COVID-19
This web page summarizes information in PubChem about patent US-2020279585-A1. This includes chemicals mentioned, as reported by PubChem contributors, as well as other content, such as title, abstract, and International Patent Classification (IPC) codes. To read more about how this page was constructed, please visit the PubChem patents help page.
NOTE: The priority date for patent application US-2020279585-A1 (and the corresponding grant US-11024339-B2) that Google has supplied is based on a series of separate-but-related patent applications dating back to 2015. Of those various applications, only US-2020279585-A1 mentions COVID-19, and it was filed on May 17, 2020. Please see the knowledgebase article on the topic: https://support.nlm.nih.gov/knowledgebase/article/KA-05327/en-us
A method is provided for acquiring and transmitting biometric data (e.g., vital signs) of a user, where the data is analyzed to determine whether the user is suffering from a viral infection, such as COVID-19. The method includes using a pulse oximeter to acquire at least pulse and blood oxygen saturation percentage, which is transmitted wirelessly to a smartphone. To ensure that the data is accurate, an accelerometer within the smartphone is used to measure movement of the smartphone and/or the user. Once accurate data is acquired, it is uploaded to the cloud (or host), where the data is used (alone or together with other vital signs) to determine whether the user is suffering from (or likely to suffer from) a viral infection, such as COVID-19. Depending on the specific requirements, the data, changes thereto, and/or the determination can be used to alert medical staff and take corresponding actions